Apelin and apelin receptor expression in renal cell carcinoma

BACKGROUND: The APLNR (apelin receptor) has been shown to be an essential gene for cancer immunotherapy, with deficiency in APLNR leading to immunotherapy failure. The aim of this study is to investigate the expression of APLN (apelin) and APLNR in patients with renal cell carcinoma (RCC), and its a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolkach, Yuri, Ellinger, Jörg, Kremer, Anika, Esser, Laura, Müller, Stefan C., Stephan, Carsten, Jung, Klaus, Toma, Marieta, Kristiansen, Glen, Hauser, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461937/
https://www.ncbi.nlm.nih.gov/pubmed/30783205
http://dx.doi.org/10.1038/s41416-019-0396-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461937/
https://www.ncbi.nlm.nih.gov/pubmed/30783205
http://dx.doi.org/10.1038/s41416-019-0396-7

Ejemplares similares